Rinvoq (upadacitinib) New Indications: Treatment of Moderate-to-Severe Ulcerative Colitis (UC)
Drug Info: ApoThera Drug Disease Clinical Support App Rinvoq (upadacitinib) receives FDA approval for the treatment of adults with moderately to severely active Ulcerative Colitis (UC) Induction Dose - 45…